COLORECTAL cancer progressively surpasses other prevalent malignancies as the principal cause of mortality among younger Americans. A comprehensive analysis of national mortality data from 1990 through 2023 evaluated temporal trends across the five leading causes of cancer death in individuals younger than 50 years. Across this period, 1,267,520 Americans died from cancer before reaching age 50, with females accounting for 53% of those deaths. While overall cancer mortality in this younger demographic declined by 44% over three decades, colorectal cancer emerged as the sole leading malignancy with a rising death rate, moving from the fifth most common cause of cancer death in the early 1990s to the first by 2023.
Investigators utilized regression modeling to quantify annual percent changes in mortality per 100,000 individuals under age 50 across five major malignancies: colorectal cancer, breast cancer, brain cancer, lung cancer, and leukemia. Beginning in 2005, colorectal cancer mortality increased by an average of 1.1% per year through 2023. In contrast, the other four leading causes of cancer mortality demonstrated steady improvements over the final decade of the study. From 2014 through 2023, mean annual mortality declines reached 5.7% for lung cancer, 2.3% for leukemia, 1.4% for breast cancer, and 0.3% for brain cancer. Sex stratified evaluations revealed that colorectal cancer became the top cause of cancer death in males under 50 and ranked second only to breast cancer among females. Furthermore, cervical cancer remained the third leading cause of cancer death in younger females despite continuous reductions, whereas pancreatic cancer replaced non Hodgkin lymphoma as the fifth leading cause among younger males by 2023.
Although the analysis relied on national ecologic mortality data, the findings highlight a critical prevention gap in clinical practice. Approximately three in four patients younger than 50 years with colorectal cancer present with advanced stage disease at diagnosis. Because screening before age 50 correlates with earlier detection and lower mortality, clinical guidelines recommend initiating colorectal cancer screening at age 45 for average risk adults and earlier for patients with genetic predisposition or family history. Primary care physicians and gastroenterologists can mitigate premature mortality by expanding colonoscopy and noninvasive screening uptake, reducing stigma, and promptly evaluating younger adults who present with red flag gastrointestinal symptoms.
Reference
Siegel RL et al. Leading cancer deaths in people younger than 50 years. JAMA. 2026;335(7):632-634.
on adobe stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
